Annual Results Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Net Sales
671.03
623.23
580.55
510.31
472.12
424.19
386.49
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
671.03
623.23
580.55
510.31
472.12
424.19
386.49
Raw Material Cost
239.57
213.94
201.12
177.00
158.48
123.43
133.73
Purchase of Finished goods
79.03
68.54
82.91
68.64
73.67
70.31
57.60
(Increase) / Decrease In Stocks
-7.44
8.84
-5.70
-4.24
-13.57
3.99
-8.41
Employee Cost
125.19
112.45
102.90
93.16
79.72
63.26
58.65
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.01
0.00
0.00
0.01
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
137.00
117.97
99.40
86.54
78.34
76.01
79.39
Total Expenditure (Excl Depreciation)
573.35
521.74
480.64
421.10
376.64
337.01
320.95
Operating Profit (PBDIT) excl Other Income
97.68
101.49
99.91
89.21
95.48
87.18
65.54
Other Income
33.45
22.48
34.42
22.47
10.00
5.66
11.04
Operating Profit (PBDIT)
131.13
123.97
134.33
111.68
105.48
92.84
76.58
Interest
1.01
1.88
1.46
2.03
1.45
1.56
2.02
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
130.12
122.09
132.87
109.65
104.03
91.28
74.56
Depreciation
14.50
12.90
10.62
9.17
8.09
7.56
7.33
Profit Before Tax
115.63
109.19
122.24
100.48
95.94
83.72
67.23
Tax
27.73
26.84
28.94
27.58
26.58
21.47
15.77
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
87.89
82.35
93.30
72.90
69.36
62.25
51.47
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
87.89
82.35
93.30
72.90
69.36
62.25
51.47
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
-0.03
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
87.89
82.35
93.30
72.90
69.36
62.25
51.44
Equity Capital
20.03
20.03
20.03
20.03
20.03
20.03
20.00
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
737.60
651.64
572.81
482.44
412.85
346.36
293.09
Earnings per share (EPS)
43.88
41.11
46.58
36.4
34.63
31.08
25.72
Diluted Earnings per share
43.88
41.11
46.58
36.4
34.63
31.07
25.72
Operating Profit Margin (Excl OI)
14.56%
16.28%
17.21%
17.48%
20.22%
20.55%
16.96%
Gross Profit Margin
19.39%
19.59%
22.89%
21.49%
22.03%
21.52%
19.29%
PAT Margin
13.1%
13.21%
16.07%
14.29%
14.69%
14.68%
13.32%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 7.67% vs 7.35% in Mar 2025
Consolidate Net Profit
YoY Growth in year ended Mar 2026 is 6.73% vs -11.74% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is -3.75% vs 1.58% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is -46.28% vs 28.77% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2026 has fallen from Mar 2025
Compare Annual Results Of Lincoln Pharma. With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
671.03
456.27
214.76
47.07%
Other Operating Income
0.00
0.00
0.00
Total Operating income
671.03
456.27
214.76
47.07%
Raw Material Cost
239.57
323.98
-84.41
-26.05%
Purchase of Finished goods
79.03
0.00
79.03
(Increase) / Decrease In Stocks
-7.44
6.05
-13.49
-222.98%
Employee Cost
125.19
22.23
102.96
463.16%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
17.56
-17.56
-100.00%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
137.00
31.54
105.46
334.37%
Total Expenditure (Excl Depreciation)
573.35
401.36
171.99
42.85%
Operating Profit (PBDIT) excl Other Income
97.68
54.91
42.77
77.89%
Other Income
33.45
0.00
33.45
Operating Profit (PBDIT)
131.13
54.91
76.22
138.81%
Interest
1.01
22.38
-21.37
-95.49%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
130.12
32.53
97.59
300.00%
Depreciation
14.50
5.04
9.46
187.70%
Profit Before Tax
115.63
27.49
88.14
320.63%
Tax
27.73
7.75
19.98
257.81%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
87.89
19.74
68.15
345.24%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
87.89
19.74
68.15
345.24%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
87.89
19.74
68.15
345.24%
Equity Capital
20.03
4.72
15.31
324.36%
Face Value
10.00
10.00
0.00
Reserves
737.60
136.68
600.92
439.65%
Earnings per share (EPS)
43.88
41.82
2.06
4.93%
Diluted Earnings per share
43.88
44.83
-0.95
-2.12%
Operating Profit Margin (Excl OI)
14.56%
12.16%
0.00
2.40%
Gross Profit Margin
19.39%
7.20%
0.00
12.19%
PAT Margin
13.10%
4.37%
0.00
8.73%
Public Share Holdings (%)
0.00%
51.07%
-51.07
-51.07%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 671.03 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 7.67% vs 7.35% in Mar 2025
Annual - Consolidate Net Profit
Consolidate Net Profit 87.89 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 6.73% vs -11.74% in Mar 2025
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 97.68 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -3.75% vs 1.58% in Mar 2025
Annual - Interest
Interest 1.01 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -46.28% vs 28.77% in Mar 2025
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 14.56%
in Mar 2026Figures in %
YoY Growth in year ended Mar 2026 has fallen from Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
